Bispecific T cell engagers for the treatment of multiple myeloma: Achievements and challenges

Authors

Kinan Alhallak, Washington University School of Medicine in St. Louis
Jennifer Sun, Washington University School of Medicine in St. Louis
Amanda Jeske, Washington University School of Medicine in St. Louis
Chaelee Park, Washington University School of Medicine in St. Louis
Jessica Yavner, Washington University School of Medicine in St. Louis
Hannah Bash, Washington University School of Medicine in St. Louis
Berit Lubben, Washington University School of Medicine in St. Louis
Ola Adebayo, Washington University School of Medicine in St. Louis
Ayah Khaskiah, Birzeit University
Abdel Kareem Azab, Washington University School of Medicine in St. Louis

Journal

Cancers (Basel)

Publication Date

2021

Volume

13

Issue

12

First Page

2853

Document Type

Open Access Publication

DOI

10.3390/cancers13122853

Rights and Permissions

Alhallak K, Sun J, Jeske A, et al. Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges. Cancers (Basel). 2021;13(12):2853. Published 2021 Jun 8. doi:10.3390/cancers13122853

Recommended Citation

Alhallak, Kinan; Sun, Jennifer; Jeske, Amanda; Park, Chaelee; Yavner, Jessica; Bash, Hannah; Lubben, Berit; Adebayo, Ola; Khaskiah, Ayah; and Azab, Abdel Kareem, "Bispecific T cell engagers for the treatment of multiple myeloma: Achievements and challenges." Cancers (Basel). 13, 12. 2853 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10452